Skip to main content
Log in

Antidepressants for functional gastrointestinal syndromes

  • Review Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Diamond S: Amitriptyline in the treatment of gastrointestinal disorders. Psychosomatics 5:221–224, 1964

    Google Scholar 

  2. Drossman DA, Thompson WG, Talley NJ, Funch-jensen P, Janssens J, Whitehead WE: Identification of sub-groups of functional gastrointestinal disorders. Gastroenterol Internat 3:159–172, 1990

    Google Scholar 

  3. Hislop IG: Psychological significance of the irritable colon syndrome. Gut 12:452–457, 1971

    Google Scholar 

  4. Clouse RE, Alpers DH: The relationship of psychiatric disorder to gastrointestinal illness. Annu Rev Med 37:283–295, 1986

    Google Scholar 

  5. Walker EA, Roy-Byrne PP, Katon WJ: Irritable bowel syndrome and psychiatric illness. Am J Psychiatry 147:565–572, 1990

    Google Scholar 

  6. Fava GA, Pavan L: Large bowel disorders. II. Psychopathology and alexithymia. Psychother Psychosom 27:100–105, 1976/1977

    Google Scholar 

  7. Latimer P, Sarna S, Campbell D, Latimer M, Waterfall W, Daniel EE: Colonic motor and myoelectric activity: a comparative study of normal subjects, psychoneurotic patients and patients with irritable bowel syndrome. Gastroenterology 80:893–901, 1981

    Google Scholar 

  8. Wender PH, Kalm M: Prevalence of attention deficit disorder, residual type, and other psychiatric disorders in patients with irritable colon syndrome. Am J Psychiatry 140:1579–1582, 1983

    Google Scholar 

  9. Robins LN, Helzer JE, Croughan J, Ratcliff KS: National Institute of Mental Health Diagnostic Interview Schedule: its history, characteristics, and validity. Arch Gen Psychiatry 38:381–389, 1981

    Google Scholar 

  10. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., revised. Washington, DC, American Psychiatric Association, 1987

    Google Scholar 

  11. Liss JL, Alpers D, Woodruff RA Jr: The irritable colon syndrome and psychiatric illness. Dis Nerv Syst 34:151–157, 1973

    Google Scholar 

  12. Young SJ, Alpers DH, Norland CC, Woodruff RA Jr: Psychiatric illness and the irritable bowel syndrome: Practical implications for the primary physician. Gastroenterology 70:162–166, 1976

    Google Scholar 

  13. Ford MJ, Miller P McC, Eastwood J, Eastwood MA: Life events, psychiatric illness and the irritable bowel syndrome. Gut 28:160–165, 1987

    Google Scholar 

  14. Walker EA, Roy-Byrne PP, Katon WJ, Li L, Amos D, Jiranek G: Psychiatric illness and irritable bowel syndrome: A comparison with inflammatory bowel disease. Am J Psychiatry 147:1656–1661, 1990

    Google Scholar 

  15. Robins LN, Helzer JE, Weissman MM, Orvaschel H, Gruenberg E, Burke JD Jr., Regier DA: Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 41:949–958, 1984

    Google Scholar 

  16. Cormier LE, Katon W, Russo J, Hollifield M, Hall ML, Vitaliano PP: Chest pain with negative cardiac diagnostic studies: Relationship to psychiatric illness. J Nerv Mental Dis 176:351–358, 1988

    Google Scholar 

  17. Beitman BD, Basha I, Flaker G, DeRosear L, Mukerji V, Lamberti JW: Major depression in cardiology chest pain patients without coronary artery disease and with panic disorder. J Affective Disord 13:51–59, 1987

    Google Scholar 

  18. Wulsin LR, Hillard JR, Geier P, Hissa D, Rouan GW: Screening emergency room patients with atypical chest pain for depression and panic disorder. Int J Psychiatry Med 18:315–323, 1988

    Google Scholar 

  19. Bass C, Wade C: Chest pain with normal coronary arteries: a comparative study of psychiatric and social morbidity. Psychol Med 14:51–61, 1984

    Google Scholar 

  20. Clouse RE, Lustman PJ: Psychiatric illness and contraction abnormalities of the esophagus. N Engl J Med 309:1337–1342, 1983

    Google Scholar 

  21. Richter JE, Baldi F, Clouse RE, Diamant NE, Janssens J, Staiano A: Functional oesophageal disorders. Gastroenterol Int 5:3–17, 1992

    Google Scholar 

  22. Richter JE, Obrecht WF, Bradley LA, Young LD, Anderson KO: Psychological comparison of patients with nutcracker esophagus and irritable bowel syndrome. Dig Dis Sci 31:131–138, 1986

    Google Scholar 

  23. Clouse RE, Lustman PJ: Value of recent psychological symptoms in identifying patients with esophageal contraction abnormalities. Psychosom Med 51:570–576, 1989

    Google Scholar 

  24. Clouse RE, Lustman PJ, Eckert TC, Ferney DM, Griffith LS: Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities: A double-blind, placebo-controlled trial. Gastroenterology 92:1027–1036, 1987

    Google Scholar 

  25. Magni G, di Mario F, Bernasconi G, Mastropaolo G: DSM-III diagnoses associated with dyspepsia of unknown cause. Am J Psychiatry 144:1222–1223, 1987

    Google Scholar 

  26. Clouse RE: Psychiatric disorders in patients with esophageal disease. Med Clin North Am 75:1081–1096, 1991

    Google Scholar 

  27. Drossman DA, McKee DC, Sandler RS, Mitchell CM, Cramer EM, Lowman BC, Burger AL: Psychosocial factors in the irritable bowel syndrome: A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 95:701–708, 1987

    Google Scholar 

  28. Smith RC, Greenbaum DS, Vancouver JB, Henry RC, Reinhart MA, Greenbaum RB, Dean HA, Mayle JE: Psychosocial factors are associated with health care seeking rather than diagnosis in irritable bowel syndrome. Gastroenterology 98:293–301, 1990

    Google Scholar 

  29. Drossman DA, Thompson WG: The irritable bowel syndrome: review and a graduated multicomponent treatment approach. Ann Intern Med 116:1009–1016, 1992

    Google Scholar 

  30. Clouse RE: Psychopharmacologic approaches to therapy for chest pain of presumed esophageal origin. Am J Med 92(suppl):106–113, 1992

    Google Scholar 

  31. Clouse RE: Anxiety and gastrointestinal illness. Psychiatr Clin North Am 11:399–415, 1988

    Google Scholar 

  32. Anderson KO, Dalton CB, Bradley LA, Richter JE: Stress induces alteration of esophageal pressures in healthy volunteers and non-cardiac chest pain patients. Dig Dis Sci 34:83–91, 1989

    Google Scholar 

  33. Valori RM, Kumar D, Wingate DL: Effects of different types of stress and of “prokinetic” drugs on the control of the fasting motor complex in humans. Gastroenterology 90:1890–1900, 1986

    Google Scholar 

  34. Keshavarzian A, Iber FL, Ferguson Y: Esophageal manometry and radionuclide emptying in chronic alcoholics. Gastroenterology 92:651–657, 1987

    Google Scholar 

  35. Wittmann T, Crenner F, Angel F, Hanusz L, Ringwald C, Greenier JF: Long-duration stress. Immediate and late effects on small and large bowel motility in rat. Dig Dis Sci 35:495–500, 1990

    Google Scholar 

  36. Cook IJ, Collins SM: Does acute emotional stress influence frequency or duration of gastroesophageal reflux in human subjects? Gastroenterology 90:A1380, 1986

  37. Bradley LA, Richter JE, Pulliam TJ, Haile JM, Scarinci IC, Schan CA, Dalton CB, Salley AN: The relationship between stress and symptoms of gastroesophageal reflux: the influence of psychological factors. Am J Gastroenterol 88:11–19, 1993

    Google Scholar 

  38. Gomez-Perez FJ, Rull JA, Dies H, Rodriguiez-Rivera JG, Gonzales-Barranco J, Lorzno-Castaneda O: Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy: A double-blind crossover study. Pain 23:395–400, 1985

    Google Scholar 

  39. Max MB, Culnane M, Schafer SC, Gracely RH, Walther DJ, Smoller B, Dubner R: Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 37:589–596, 1987

    Google Scholar 

  40. Turkington RW: Depression masquerading as diabetic neuropathy. JAMA 243:1147–1150, 1980

    Google Scholar 

  41. Couch JR, Ziegler DK, Hassanein R: Amitriptyline in the prophylaxis of migraine. Neurology 26:121–127, 1976

    Google Scholar 

  42. Gomersall JD, Stuart A: Amitriptyline in migraine prophylaxis. J Neurol Neurosurg Psychiatry 36:684–690, 1973

    Google Scholar 

  43. Watson CP, Evans RJ, Reed K, Merskey H, Goldsmith L, Warsh J: Amitriptyline versus placebo in postherpetic neuralgia. Neurology 32:671–673, 1982

    Google Scholar 

  44. MacNeill AL, Dick WC: Imipramine and rheumatoid factor. J Int Med Res 4:23–27, 1976

    Google Scholar 

  45. Fernandez F, Adams F, Holmes F: Analgesic effect of alprazolam in patients with chronic, organic pain of malignant origin. J Clin Psychopharmacol 3:167–169, 1987

    Google Scholar 

  46. Egbunike IG, Chaffee BJ: Antidepressants in the management of chronic pain syndromes. Pharmacotherapy 10:262–270, 1990

    Google Scholar 

  47. France RD: The future for antidepressants: treatment of pain. Psychopathology 20(suppl 1):99–113, 1987

    Google Scholar 

  48. Getto CJ, Sorkness CA, Howell T: Antidepressants and chronic nonmalignant pain: A review. J Pain Symptom Manage 2:9–18, 1987

    Google Scholar 

  49. Satterthwaite JR, Tollison CD, Kriegel ML: The use of tricyclic antidepressants for the treatment of intractable pain. Compr Ther 16:10–15, 1990

    Google Scholar 

  50. Heefner JD, Russell MW, Wilson ID: Irritable colon and depression. Psychosomatics 19:540–547, 1978

    Google Scholar 

  51. Steinhart MJ, Wong PY, Zarr ML: Therapeutic usefulness of amitriptyline in spastic colon syndrome. Int J Psychiatry Med 11:45–57, 1981–1982

    Google Scholar 

  52. Myren J, Groth H, Larssen SE, Larsen S: The effect of trimipramine in patients with the irritable bowel syndrome. Scand J Gastroenterol 17:871–875, 1982

    Google Scholar 

  53. Lancaster-Smith MJ, Prout BJ, Pinto T, Anderson JA, Schiff AA: Influence of drug treatment on the irritable bowel syndrome and its interaction with psychoneurotic morbidity. Acta Psychiatr Scand 66:33–41, 1982

    Google Scholar 

  54. Gartrell N, Mosbacher D: A case report of the irritable bowel syndrome treated with doxepin. Am J Psychiatry 139:1351–1354, 1982

    Google Scholar 

  55. Shrivastava RK, Siegel H: The role of tricyclics and benzodiazepine compounds in the treatment of irritable gut syndrome and peptic ulcer disease. Psychopharm Bull 20:616–621, 1984

    Google Scholar 

  56. Greenbaum DS, Mayle JE, Vanegeren LE, Jerome JA, Mayor JW, Greenbaum RB, Matson RW, Stein GE, Dean HA, Halvorsen NA, Rosen LW: Effects of desipramine on irritable bowel syndrome compared with atropine and placebo. Dig Dis Sci 32:257–266, 1987

    Google Scholar 

  57. Klein KB: Controlled treatment trials in the irritable bowel syndrome: A critique. Gastroenterology 95:232–241, 1988

    Google Scholar 

  58. Mayer EA, Raybould HE: Role of visceral afferent mechanisms in functional bowel disorders. Gastroenterology 99:1688–1704, 1990

    Google Scholar 

  59. Ritchie J: Pain from distention of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut 14:125–132, 1973

    Google Scholar 

  60. Whitehead WE, Holtkotter B, Enck P, Hoelzl R, Holmes KD, Anthony J, Shabsin H, Schuster MM: Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology 98:1187–1192, 1990

    Google Scholar 

  61. Richter JE, Barish CF, Castell DO: Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology 91:845–852, 1986

    Google Scholar 

  62. Lemann M, Dederding JP, Flourie B, Franchisseur C, Rambaud JC, Jian R: Abnormal perception of visceral pain in response to gastric distention in chronic idiopathic dyspepsia: The irritable stomach syndrome. Dig Dis Sci 36:1249–1254, 1991

    Google Scholar 

  63. Clouse RE, McCord GS, Lustman PJ, Edmundowicz SA: Clinical correlates of abnormal sensitivity to intraesophageal balloon distension. Dig Dis Sci 36:1040–1045, 1991

    Google Scholar 

  64. Mearin F, Cucala M, Azpiroz F, Malagelada J-R: The origin of symptoms on the brain-gut axis in functional dyspepsia. Gastroenterology 101:999–1006, 1991

    Google Scholar 

  65. Bradette M, Pare P, Douville P, Morin A: Visceral perception in health and functional dyspepsia. Crossover study of gastric distension with placebo and domperidone. Dig Dis Sci 36:52–58, 1991

    Google Scholar 

  66. George AA, Tsuchiyose M, Dooley CP: Sensitivity of the gastric mucosa to acid and duodenal contents in patients with nonulcer dyspepsia. Gastroenterology 101:3–6, 1991

    Google Scholar 

  67. Talley NJ: Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: Clinical implications. Aliment Pharmacol Ther 6:273–289, 1992

    Google Scholar 

  68. Baldessarini RJ: Current status of antidepressants: Clinical pharmacology and therapy. J Clin Psychiatry 50:117–126, 1989

    Google Scholar 

  69. Rudorfer MV, Potter WZ: Antidepressants: A comparative review of the clinical pharmacology and therapeutic use of the “newer” versus the “older” drugs. Drugs 37:713–738, 1989

    Google Scholar 

  70. Stark M Jr, Maher K, Gupta P, Epstein S, Cannon R, Lewis J, Benjamin S: Visceral afferent blockade with ondansetron (Zofran) increases nociceptive thresholds in patients with chest pain of undetermined etiology (CPUE). Am J Gastroenterol 86:1305 (abstract), 1991

    Google Scholar 

  71. Hasler WL, Soudah HC, Owyang C: A somatostatin analogue inhibits afferent pathways mediating perception of rectal distention. Gastroenterology 104:1390–1397, 1993

    Google Scholar 

  72. Blackwell B: A biopsychosocial perspective to psychotropic drug use in psychophysiologic conditions. Psychopharmacol Bull 20:629–634, 1984

    Google Scholar 

  73. Camilleri M, Prather CM: The irritable bowel syndrome: mechanisms and a practical approach to management. Ann Intern Med 116:1001–1008, 1992

    Google Scholar 

  74. Clouse RE, Lustman PJ, Geisman RA, Alpers DH: Antidepressant therapy in 138 patients with irritable bowel syndrome: A five-year clinical experience. Aliment Pharmacol Ther 8:1994

  75. Holmes KM, Salter RH: Irritable bowel syndrome—a safe diagnosis? Br Med J 285:1533–1534, 1982

    Google Scholar 

  76. Hawkins CF, Cockel R: The prognosis and risk of missing malignant disease in patients with unexplained and functional diarrhoea. Gut 12:208–211, 1971

    Google Scholar 

  77. Harvey RF, Mauad EC, Brown AM: Prognosis in the irritable bowel syndrome: A 5-year prospective study. Lancet 1:963–965, 1987

    Google Scholar 

  78. Waller SL, Misiewicz JJ: Prognosis in the irritable-bowel syndrome. A prospective study. Lancet 2:753–756, 1969

    Google Scholar 

  79. Appleton WS: Fourth psychoactive drug usage guide. J Clin Psychiatry 43:12–27, 1982

    Google Scholar 

  80. Dawson GW, Jue SG, Brogden RN: Alprazolam: A review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression. Drugs 27:132–147, 1984

    Google Scholar 

  81. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R: Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326:1250–1256, 1992

    Google Scholar 

  82. US Department of Health and Human Services, Public Health Service: Depression in Primary Care: Detection, Diagnosis, and Treatment, Vol 5. AHCPR Publication No. 93-0552, April 1993

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Clouse, R.E. Antidepressants for functional gastrointestinal syndromes. Digest Dis Sci 39, 2352–2363 (1994). https://doi.org/10.1007/BF02087651

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02087651

Key words

Navigation